Skip to main content
. Author manuscript; available in PMC: 2016 May 1.
Published in final edited form as: Brain Pathol. 2015 May;25(3):289–303. doi: 10.1111/bpa.12247

Table 3.

Tier 1 overall positive outcome rates. Dose groups that achieve the required positive outcome rate to be considered promising as defined by our Tier 1 effectiveness evaluation plan are shaded in yellow.

Group Outcome (Vehicle) 0 mg/kg/day 10 mg/kg/day 20 mg/kg/day 40 mg/kg/day 60 mg/kg/day
1-h RNR Pathology 4/20 0/10 1/10 2/10 0/10
Mitochondria 10/20 6/10 4/10 5/10 4/10
Total positive outcome rate 14/40 (35%) 6/20 (30%) 5/20 (25%) 7/20 (35%) 4/20 (20%)
6-h RNR Pathology 2/10 2/10 4/10 1/10 3/10
Mitochondria 5/10 7/10 6/10 5/10 6/10
Total positive outcome rate 7/20 (35%) 9/20 (45%) 10/20 (50%) 6/20 (30%) 9/20 (45%)
1-h CCI Pathology 4/20 1/10 4/10 2/10 6/10
Mitochondria 9/20 6/10 4/10 6/10 5/10
Total positive outcome rate 13/40 (33%) 7/20 (35%) 8/20 (40%) 8/20 (40%) 11/20 (55%)
6-h CCI Pathology 2/10 4/10 5/10 3/10 4/10
Mitochondria 5/10 7/10 4/10 3/10 5/10
Total positive outcome rate 6/20 (30%) 11/20 (55%) 9/20 (45%) 6/20 (30%) 9/20 (45%)

Abbreviations: RNR = rapid nonimpact rotation; CCI = controlled cortical impact.